Moon Capital Management’s Evogene EVGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-28,068
Closed -$331K 27
2020
Q1
$331K Sell
28,068
-8,506
-23% -$117K 0.31% 21
2019
Q4
$556K Hold
36,574
0.76% 12
2019
Q3
$578K Hold
36,574
0.21% 16
2019
Q2
$589K Sell
36,574
-13,537
-27% -$251K 0.2% 18
2019
Q1
$917K Hold
50,111
0.45% 25
2018
Q4
$992K Buy
50,111
+264
+0.5% +$6.67K 0.62% 20
2018
Q3
$1.55M Buy
49,847
+455
+0.9% +$13.1K 0.76% 17
2018
Q2
$1.41M Buy
49,392
+914
+2% +$27.9K 0.8% 15
2018
Q1
$1.54M Hold
48,478
0.74% 17
2017
Q4
$1.49M Buy
48,478
+11,958
+33% +$470K 0.46% 22
2017
Q3
$1.62M Buy
36,520
+10,609
+41% +$505K 0.44% 20
2017
Q2
$1.31M Buy
25,911
+224
+0.9% +$11.6K 0.34% 25
2017
Q1
$1.37M Buy
25,687
+5,032
+24% +$262K 0.42% 25
2016
Q4
$1.05M Buy
20,655
+5,645
+38% +$323K 0.35% 22
2016
Q3
$958K Buy
15,010
+66
+0.4% +$4.34K 0.36% 24
2016
Q2
$933K Buy
14,944
+2,632
+21% +$183K 0.36% 26
2016
Q1
$802K Buy
12,312
+5,628
+84% +$386K 0.36% 26
2015
Q4
$538K Buy
6,684
+2,946
+79% +$219K 0.29% 22
2015
Q3
$308K Buy
3,738
+90
+2% +$7.84K 0.18% 19
2015
Q2
$322K Hold
3,648
0.18% 20
2015
Q1
$322K Buy
3,648
+98
+3% +$9.13K 0.18% 21
2014
Q4
$327K Buy
+3,550
New +$376K 0.21% 18
2014
Q2
Sell
-1,812
Closed -$345K 25
2014
Q1
$345K Sell
1,812
-4,968
-73% -$941K 0.2% 27
2013
Q4
$1.33M Buy
+6,780
New +$1.25M 0.81% 23

Other funds holding EVGN

Moon Capital Management's EVGN Position: Q2 2020 in Review

Moon Capital Management sold out of Evogene (EVGN) in Q2 2020, closing a stake of 28,068 shares — an estimated $331K sold.

Moon Capital Management first reported a position in EVGN in Q4 2013 and held it in 24 quarters. The position peaked at $1.62M in Q3 2017. 18 funds tracked by Wall St. Rank hold EVGN as of Q2 2020.

  • Moon Capital Management reported no remaining Evogene position as of Q2 2020 after selling out during the quarter.
  • Moon Capital Management sold 28,068 Evogene shares in Q2 2020, an estimated $331K.
  • Moon Capital Management first reported a position in Evogene in Q4 2013 and held it in 24 quarters.
  • Moon Capital Management's Evogene position peaked at $1.62M in Q3 2017.
  • 18 funds tracked by Wall St. Rank held Evogene as of Q2 2020.

Based on Moon Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.